Bausch Health Companies Inc (BHC) is a publicly traded Healthcare sector company. As of May 21, 2026, BHC trades at $5.42 with a market cap of $1.99B and a P/E ratio of 13.20. BHC moved +3.48% today. Year to date, BHC is -25.68%; over the trailing twelve months it is +17.52%. Its 52-week range spans $4.25 to $9.85. Analyst consensus is neutral with an average price target of $7.00. Rallies surfaces BHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bausch Health Q1 Revenues Jump 12% to $2.52B Despite $1.426B Impairment: Bausch Health posted Q1 revenues of $2.52B, a 12% increase (7% organic), alongside a $1.423B GAAP net loss driven by a $1.426B goodwill impairment. Non-GAAP adjusted EPS rose 32% to $0.78, adjusted EBITDA climbed 27% to $837M, and operating cash flow reached $319M, with full-year 2026 guidance reaffirmed.
| Metric | Value |
|---|---|
| Price | $5.42 |
| Market Cap | $1.99B |
| P/E Ratio | 13.20 |
| EPS | $0.42 |
| Dividend Yield | 1.00% |
| 52-Week High | $9.85 |
| 52-Week Low | $4.25 |
| Volume | 8 |
| Avg Volume | 0 |
| Revenue (TTM) | $10.27B |
| Net Income | $120.00M |
| Gross Margin | 0.00% |
6 analysts cover BHC: 0 strong buy, 0 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.00.